Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPurple Biotech Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2025 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q3 2025 | 1 | -$0.26 | -$0.26 | -$0.26 |
| Q4 2025 | 1 | -$0.34 | -$0.34 | -$0.34 |
| Q1 2026 | 1 | -$0.39 | -$0.39 | -$0.39 |
| Q2 2026 | 1 | -$0.45 | -$0.45 | -$0.45 |
| Q3 2026 | 1 | -$0.51 | -$0.51 | -$0.51 |
| Q4 2026 | 1 | -$0.58 | -$0.58 | -$0.58 |
Purple Biotech Ltd. Earnings Date And Information
Purple Biotech Ltd. last posted its earnings results on Friday, November 14th, 2025. The company reported $-0.29 earnings per share for the quarter, missing analysts' consensus estimates of $-0.26 by $0.03. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Purple Biotech Ltd. has generated $-4 earnings per share over the last year ($-4.42 diluted earnings per share) and currently has a price-to-earnings ratio of -0.84. Purple Biotech Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 11th, 2026 based on prior year's report dates.
Purple Biotech Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/29/2025 | Q3 2025 | N/A | -$58.00 | N/A | $0 | $0 |
| 08/06/2025 | Q2 2025 | -$0.21 | -$80.00 | -79.79 | $0 | $0 |
| 03/31/2025 | Q1 2025 | N/A | -$34.00 | N/A | $0 | $0 |
| 03/10/2025 | Q4 2024 | -$0.22 | -$0.20 | 0.02 | $0 | $0 |
| 09/30/2024 | Q3 2024 | N/A | -$0.38 | N/A | $0 | $0 |
| 06/29/2024 | Q2 2024 | N/A | -$0.02 | N/A | $0 | $0 |
| 03/30/2024 | Q1 2024 | N/A | -$0.03 | N/A | N/A | $0 |
| 12/30/2023 | Q4 2023 | N/A | -$0.04 | N/A | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$0.05 | N/A | N/A | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$0.05 | N/A | N/A | $0 |
| 03/30/2023 | Q1 2023 | N/A | -$0.05 | N/A | N/A | $0 |
| 12/30/2022 | Q4 2022 | N/A | -$0.07 | N/A | N/A | $0 |
| 09/29/2022 | Q3 2022 | N/A | -$0.05 | N/A | N/A | $0 |
| 06/29/2022 | Q2 2022 | N/A | -$0.04 | N/A | N/A | $0 |
| 03/30/2022 | Q1 2022 | N/A | -$0.08 | N/A | N/A | $0 |
| 12/30/2021 | Q4 2021 | N/A | -$5.00 | N/A | N/A | $0 |
| 09/29/2021 | Q3 2021 | N/A | -$3.58 | N/A | N/A | $0 |
| 06/29/2021 | Q2 2021 | N/A | -$4.14 | N/A | N/A | $0 |
| 03/30/2021 | Q1 2021 | N/A | -$7.54 | N/A | N/A | $0 |
| 12/30/2020 | Q4 2020 | N/A | -$0.52 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Purple Biotech Ltd. Earnings: FAQ's
Purple Biotech Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 11th, 2026 based offlast year's report dates.
The conference call for Purple Biotech Ltd.'s latest earnings report can be listened to online.
The conference call transcript for Purple Biotech Ltd.'s latest earnings report can be read online.
Purple Biotech Ltd. (:PPBT) has a recorded net income of $-7,240,000.Purple Biotech Ltd. has generated $-4.42 earnings per share over the last four quarters.
Purple Biotech Ltd. (:PPBT) has a price-to-earnings ratio of -0.84 and price/earnings-to-growth ratio is 0.01.